Dr Rupa Pike, Sr. Director & Global Head Strategic Alliances and Field Scientists for Cell Therapy, Catalent, shares insight on de-risking cell therapy programs using streamlined development and manufacturing platforms.
Nirupama (Rupa) Pike, PhD
Advertisement
Articles by Nirupama (Rupa) Pike, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
2
New Targets for Clinical Trials in the European Union
3
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
4
Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation
5
